SE8901278L - Peptidderivat - Google Patents

Peptidderivat

Info

Publication number
SE8901278L
SE8901278L SE8901278A SE8901278A SE8901278L SE 8901278 L SE8901278 L SE 8901278L SE 8901278 A SE8901278 A SE 8901278A SE 8901278 A SE8901278 A SE 8901278A SE 8901278 L SE8901278 L SE 8901278L
Authority
SE
Sweden
Prior art keywords
hydrogen
residue
physiologically
formula
peptide
Prior art date
Application number
SE8901278A
Other languages
Unknown language ( )
English (en)
Swedish (sv)
Other versions
SE8901278D0 (sv
Inventor
R Albert
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888808442A external-priority patent/GB8808442D0/en
Priority claimed from GB888826452A external-priority patent/GB8826452D0/en
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8901278D0 publication Critical patent/SE8901278D0/xx
Publication of SE8901278L publication Critical patent/SE8901278L/

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Psychiatry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
SE8901278A 1988-04-11 1989-04-10 Peptidderivat SE8901278L (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888808442A GB8808442D0 (en) 1988-04-11 1988-04-11 Peptide derivatives
GB888826452A GB8826452D0 (en) 1988-11-11 1988-11-11 Peptide derivatives

Publications (2)

Publication Number Publication Date
SE8901278D0 SE8901278D0 (sv) 1989-04-10
SE8901278L true SE8901278L (sv) 1989-10-12

Family

ID=26293760

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8901278A SE8901278L (sv) 1988-04-11 1989-04-10 Peptidderivat

Country Status (14)

Country Link
JP (1) JPH01305098A (fr)
AU (1) AU3263989A (fr)
BE (1) BE1003200A4 (fr)
CH (1) CH677795A5 (fr)
DE (1) DE3910667A1 (fr)
DK (1) DK171489A (fr)
ES (1) ES2013431A6 (fr)
FR (1) FR2629824B1 (fr)
GB (1) GB2224280B (fr)
IL (1) IL89897A0 (fr)
IT (1) IT1231943B (fr)
LU (1) LU87496A1 (fr)
NL (1) NL8900882A (fr)
SE (1) SE8901278L (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1288224B1 (fr) * 1993-08-09 2008-06-25 Societe De Conseils De Recherches Et D'applications Scientifiques S.A.S. Derivées des peptides therapeutiques
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4139526A (en) * 1977-12-01 1979-02-13 Merck & Co., Inc. Somatostatin analogs
HUT42101A (en) * 1985-01-07 1987-06-29 Sandoz Ag Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds
JPH085913B2 (ja) * 1985-09-12 1996-01-24 ザ・アドミニストレ−タ−ズ・オブ・ザ・ツ−レイン・エデユケイシヨナル・フアンド 治療用ソマトスタチン同族体
HU206890B (en) * 1986-10-13 1993-01-28 Sandoz Ag Process for producing sugar-modified somatostatin peptide derivatives and pharmaceutical compositions containing them as active components

Also Published As

Publication number Publication date
CH677795A5 (fr) 1991-06-28
FR2629824A1 (fr) 1989-10-13
ES2013431A6 (es) 1990-05-01
IT8947833A0 (it) 1989-04-10
AU3263989A (en) 1989-10-12
LU87496A1 (fr) 1989-11-14
IT1231943B (it) 1992-01-16
DK171489A (da) 1989-10-12
GB8907902D0 (en) 1989-05-24
SE8901278D0 (sv) 1989-04-10
GB2224280A (en) 1990-05-02
JPH01305098A (ja) 1989-12-08
GB2224280B (en) 1992-07-08
FR2629824B1 (fr) 1995-03-10
IL89897A0 (en) 1989-12-15
NL8900882A (nl) 1989-11-01
DK171489D0 (da) 1989-04-10
BE1003200A4 (fr) 1992-01-14
DE3910667A1 (de) 1989-10-19

Similar Documents

Publication Publication Date Title
DK0728148T3 (da) Forbedrede immunogene sammensætninger mod humant gastrin 17
ZA9395B (en) A human kunitz-type protease inhibitor variant
MX9800418A (es) Analogos de la hormona paratiroidea.
PT1188768E (pt) Peptídeos antagonistas de lhrh
NO981395L (no) Cykliske peptidanaloger av somatostatin
IL92671A0 (en) Pharmaceutical compositions containing peptide isosteres as retroviral protease inhibitors
NO960939L (no) Kininogenaseinhibitor
SE9101838D0 (sv) Novel peptides and their use
ES2012720A6 (es) Procedimiento para la obtencion de sales de adicion de acido de taurina o glicina amidada.
EP0751148A3 (fr) Analogues de substitution des peptides de magainine contenant un D-amino acide
GR852541B (fr)
GB1533077A (en) 4-substituted enkephalin derivatives
SE8901278D0 (sv) Peptide derivatives
DE3569541D1 (en) Pharmacologically active peptides
DE3467581D1 (en) Gastric secretion inhibiting peptide derivatives, process for their preparation and medicines containing them
ES8801307A1 (es) Un procedimiento para preparar un material peptidico que tiene actividad humoral timica
NZ511747A (en) Regulatory/unfolding peptides of ezrin
CA2076749A1 (fr) Derives vasoactifs de la vasotocine
ES2058290T3 (es) Analogos de somatostatina terapeuticos.
NO901558L (no) Vasoaktive peptider.
ATE162850T1 (de) Phospholipase c inhibitierendes peptid
AU5898799A (en) Deoxyhypusine reagent and peptides
ATE87939T1 (de) Glycosylierte aminosaeuren und peptide.

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 8901278-5

Effective date: 19921101